Lixisenatide - Sanofi
At a glance
- Drug Originator Zealand Pharma
- Drug Licenced by Sanofi
- Drug Class Antihyperglycaemics; Peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists
- USA Patent Applicants SANOFI-AVENTIS US
- USA Patents 76
- BLAs 1
- International Patents 979

Disclaimer